US$ 23.55
glp 1 ra heart failure The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 receptor agonist-based therapies and
Description
Ardmore Institute of Health is delighted to offer a AAFP credit system approved, free CME, Prescribing GLP-1 RA Medications and Lifestyle Habits to Maximize Patient Success.

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

A more mindful, wellness-forward approach to GLP-1 use

The pill era has ushered in a Wild-West-style land-grab for GLP-1 market share but the horizon seems to keep expanding.

Its time to take a proactive step towards your wellness.
Psoriatic disease (PsD) is a chronic systemic inflammatory condition associated with significant cardiometabolic comorbidities, including obesity, type 2 diabetes mellitus (T2DM), and cardiovascular (CV) disease
